Investors' Chronicle cover image

How to pass on wealth, AstraZeneca & Ceres: The Companies and Markets Show

Investors' Chronicle

00:00

Financial health, profitability timeline, and valuation

Mark reviews Ceres' cash position, burn rate, valuation metrics, and the need for more deals to justify upside.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app